Irritability
feeling effect
AI-inferred — this entry was drafted by AI and has not yet been verified against primary sources. A sourced revision is planned.
Irritability is a lowered threshold for frustration and reactive anger that arises as a direct drug effect.
As a drug effect it is acute and dose-proportional, easing as the substance wears off; this distinguishes it from a standing mood disorder. It ranges from mild edginess and heightened impatience to sharp, hair-trigger anger that strains relationships and narrows deliberate thought.
Irritability is among the more commonly reported adverse mood effects. It is most commonly induced at moderate to high doses under stimulants such as amphetamine, MDMA, and cocaine, and as a rebound from depressants like alcohol and alprazolam and from opioids such as oxycodone and kratom as they wear off. It also appears under nootropics such as phenylpiracetam and piracetam.
phenomenology
Irritability is felt as a persistent low-grade agitation sitting just beneath the surface: thoughts sharpen toward perceived slights, patience erodes quickly, and minor obstacles provoke disproportionate frustration. It commonly comes with jaw and shoulder tension, a restless inability to settle, and heightened sensitivity to noise or interruption.
Attending to it tends to amplify it — noticing the agitation feeds further irritation. At higher doses, particularly under stimulants, it can sharpen into hostile reactivity.
mechanism
Irritability arises through different pathways depending on the drug class:
- Stimulants — elevate dopamine and norepinephrine, overstimulating arousal circuits and lowering frustration tolerance.
- Depressants — produce irritability primarily as a rebound; as GABA-active substances wear off, withdrawal of inhibitory tone is felt as edginess and agitation.
- Opioids — similarly generate rebound irritability during offset, accompanied by dysphoria as mu-opioid activity falls.
- Nootropics — can produce irritability at high doses, likely via excitatory overstimulation.
How much each pathway contributes in a given case is not fully understood.
variability
Who experiences it, and how strongly, varies widely. Dose is the strongest predictor — higher doses across all classes raise both likelihood and intensity.
Set and setting play a role too — existing stress, fatigue, or social tension heighten it, especially under stimulants — as does a disposition toward low frustration tolerance or a history of mood dysregulation. Anticipating a difficult come-down tends to prime it. Adequate rest and a calm baseline going in tend to reduce it.
substances
practices
experience reports
No experience reports yet. Be the first to contribute.
First-person accounts of subjective effects, timing, and outcomes — submitted for harm reduction.
AI-generated · claude-sonnet-4-6 · reviewed
Harm-reduction reference — not medical advice.